Bausch Health
BHC
#3695
Rank
NZ$4.92 B
Marketcap
$13.36
Share price
0.39%
Change (1 day)
12.53%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.62. In 2022 the company made an earnings per share (EPS) of -$1.08 an increase over its 2021 EPS that were of -$4.62.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.29297.1%
2022-$1.08-76.64%
2021-$4.6268.45%
2020-$2.74-68.91%
2019-$8.83-57.11%
2018-$20.58-272.22%
2017$11.95-199.29%
2016-$12.03798.7%
2015-$1.34-128.31%
2014$4.73-204.62%
2013-$4.52602.7%
2012-$0.64-171.15%
2011$0.90-143.96%
2010-$2.06-206.57%
2009$1.93-11.2%
2008$2.172.46%
2007$2.12-7.58%
2006$2.30-14.29%
2005$2.6854%
2004$1.74-500%
2003-$0.43-141.67%
2002$1.04-4.76%
2001$1.10-175%
2000-$1.46-268%
1999$0.8714.94%
1998$0.7620.83%
1997$0.6353.83%
1996$0.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.74-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.47-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA